• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

rs6265 多态性与多发性硬化认知障碍的关联:一项墨西哥患者的病例对照研究。

Association of the rs6265 Polymorphism with Cognitive Impairment in Multiple Sclerosis: A Case-Control Study in Mexican Patients.

机构信息

Departamento de Psicología Aplicada, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Ameca 46600, Mexico.

Instituto de Terapéutica Experimental y Clínica, Departamento de Fisiología, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Ameca 46600, Mexico.

出版信息

Genes (Basel). 2023 Nov 26;14(12):2130. doi: 10.3390/genes14122130.

DOI:10.3390/genes14122130
PMID:38136952
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10742426/
Abstract

Cognition is a set of brain processes that allow the individual to interact with their environment. Multiple sclerosis (MS) is a chronic inflammatory disease that affects the cerebral white matter of the brain cortex and spinal cord, leading to cognitive impairment (CI) in 40-60% of the patients. Many studies have determined that CI is linked to genetic risk factors. We aimed to evaluate the association between gene rs6265 polymorphism and cognitive impairment in Mexican patients with MS by performing a case-control study. Mestizo-Mexican patients diagnosed with MS based on McDonald's criteria were enrolled. Cases were MS patients with CI ( = 31) while controls were MS patients without CI ( = 31). To measure cognitive functioning in MS patients, a neuropsychological screening battery for MS (NSB-MS) was used. Genotyping of the rs6265 gene variant was performed using quantitative real-time PCR (qPCR) with TaqMan probes. The results showed no statistically significant differences in sociodemographic and disease variables between case and control groups. qPCR analysis showed that there were 68% Val/Val wild-type homozygotes, 29% Val/Met polymorphic heterozygotes, and 3% Met/Met polymorphic homozygotes. The presence of gene rs6265 polymorphism showed an increased probability (3.6 times) of global cognitive impairment.

摘要

认知是一组大脑过程,使个体能够与环境互动。多发性硬化症(MS)是一种慢性炎症性疾病,影响大脑皮层和脊髓的脑白质,导致 40-60%的患者出现认知障碍(CI)。许多研究已经确定,CI 与遗传风险因素有关。我们通过进行病例对照研究,旨在评估基因 rs6265 多态性与墨西哥 MS 患者认知障碍之间的关联。入组了基于 McDonald 标准诊断为 MS 的梅斯蒂索-墨西哥裔患者。病例为有 CI 的 MS 患者(=31),而对照组为无 CI 的 MS 患者(=31)。为了测量 MS 患者的认知功能,使用 MS 的神经心理学筛查量表(NSB-MS)进行了测试。使用 TaqMan 探针的定量实时 PCR(qPCR)对 rs6265 基因变异进行了基因分型。结果显示,病例组和对照组在社会人口统计学和疾病变量方面无统计学显著差异。qPCR 分析显示,68%为 Val/Val 野生型纯合子,29%为 Val/Met 多态性杂合子,3%为 Met/Met 多态性纯合子。基因 rs6265 多态性的存在显示出全球认知障碍的可能性增加(3.6 倍)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/384c/10742426/99e21baf891d/genes-14-02130-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/384c/10742426/274971691780/genes-14-02130-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/384c/10742426/99e21baf891d/genes-14-02130-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/384c/10742426/274971691780/genes-14-02130-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/384c/10742426/99e21baf891d/genes-14-02130-g002.jpg

相似文献

1
Association of the rs6265 Polymorphism with Cognitive Impairment in Multiple Sclerosis: A Case-Control Study in Mexican Patients.rs6265 多态性与多发性硬化认知障碍的关联:一项墨西哥患者的病例对照研究。
Genes (Basel). 2023 Nov 26;14(12):2130. doi: 10.3390/genes14122130.
2
Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer.脑源性神经营养因子基因多态性(rs6265)对早期乳腺癌患者化疗相关认知障碍具有保护作用。
Neuro Oncol. 2016 Feb;18(2):244-51. doi: 10.1093/neuonc/nov162. Epub 2015 Aug 19.
3
[Association of Val66Met polymorphism of brain-derived neurotrophic factor gene with cognitive impairment and clinical symptoms in first episode schizophrenia].脑源性神经营养因子基因Val66Met多态性与首发精神分裂症认知损害及临床症状的相关性
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2017 Aug 10;34(4):592-596. doi: 10.3760/cma.j.issn.1003-9406.2017.04.027.
4
BDNF G196A (Val66Met) polymorphism associated with cognitive impairment in Parkinson's disease.脑源性神经营养因子 G196A(Val66Met)多态性与帕金森病认知障碍相关。
Neurosci Lett. 2014 Feb 21;561:86-90. doi: 10.1016/j.neulet.2013.12.051. Epub 2014 Jan 3.
5
Brain-derived neurotrophic factor Val66Met polymorphism is associated with mild cognitive impairment in elderly patients with type 2 diabetes: a case-controlled study.脑源性神经营养因子 Val66Met 多态性与老年 2 型糖尿病患者轻度认知功能障碍的关系:一项病例对照研究。
Aging Clin Exp Res. 2021 Jun;33(6):1659-1666. doi: 10.1007/s40520-020-01687-w. Epub 2020 Sep 6.
6
The effects of BDNF Val66Met polymorphism on brain function in controls and patients with multiple sclerosis: an imaging genetic study.BDNF Val66Met 多态性对多发性硬化症患者和对照者脑功能的影响:一项影像学遗传学研究。
Behav Brain Res. 2010 Mar 5;207(2):377-86. doi: 10.1016/j.bbr.2009.10.022. Epub 2009 Oct 27.
7
Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers.精神分裂症患者和健康志愿者中脑源性神经营养因子Val66Met基因多态性的认知及磁共振成像脑形态学相关性
Arch Gen Psychiatry. 2006 Jul;63(7):731-40. doi: 10.1001/archpsyc.63.7.731.
8
Preservation of gray matter volume in multiple sclerosis patients with the Met allele of the rs6265 (Val66Met) SNP of brain-derived neurotrophic factor.脑源性神经营养因子rs6265(Val66Met)单核苷酸多态性的Met等位基因对多发性硬化症患者灰质体积的保护作用
Hum Mol Genet. 2007 Nov 15;16(22):2659-68. doi: 10.1093/hmg/ddm189. Epub 2007 Jul 26.
9
[BDNF gene RS6265 polymorphism in patients with multiple sclerosis of Tomsk region].[托木斯克地区多发性硬化症患者的脑源性神经营养因子基因RS6265多态性]
Zh Nevrol Psikhiatr Im S S Korsakova. 2023;123(5):160-164. doi: 10.17116/jnevro2023123051160.
10
Prediction of the cognitive impairment development in patients with autoimmune thyroiditis and hypothyroidism.预测自身免疫性甲状腺炎和甲状腺功能减退症患者的认知障碍发展。
Endocr Regul. 2022 Jul 13;56(3):178-189. doi: 10.2478/enr-2022-0019.

本文引用的文献

1
New Frontiers in Neurodegeneration and Regeneration Associated with Brain-Derived Neurotrophic Factor and the rs6265 Single Nucleotide Polymorphism.脑源性神经营养因子与 rs6265 单核苷酸多态性相关的神经退行性变和再生的新前沿。
Int J Mol Sci. 2022 Jul 20;23(14):8011. doi: 10.3390/ijms23148011.
2
The immunology of multiple sclerosis.多发性硬化症的免疫学
Nat Rev Immunol. 2022 Dec;22(12):734-750. doi: 10.1038/s41577-022-00718-z. Epub 2022 May 4.
3
Validation of the Norma Latina neuropsychological assessment battery in individuals with multiple sclerosis in Mexico.
拉丁诺医学神经心理学评估量表在墨西哥多发性硬化症患者中的验证。
Mult Scler Relat Disord. 2022 Mar;59:103685. doi: 10.1016/j.msard.2022.103685. Epub 2022 Feb 12.
4
Polymorphisms CYP2R1 rs10766197 and CYP27B1 rs10877012 in Multiple Sclerosis: A Case-Control Study.CYP2R1 rs10766197 和 CYP27B1 rs10877012 多态性与多发性硬化症的病例对照研究。
J Immunol Res. 2021 Dec 23;2021:7523997. doi: 10.1155/2021/7523997. eCollection 2021.
5
Apparent changes in the epidemiology and severity of multiple sclerosis.多发性硬化症的流行病学和严重程度的明显变化。
Nat Rev Neurol. 2021 Nov;17(11):676-688. doi: 10.1038/s41582-021-00556-y. Epub 2021 Sep 28.
6
Identifying the Distinct Cognitive Phenotypes in Multiple Sclerosis.识别多发性硬化症中的独特认知表型。
JAMA Neurol. 2021 Apr 1;78(4):414-425. doi: 10.1001/jamaneurol.2020.4920.
7
Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues.多发性硬化症的认知障碍:临床管理、MRI 和治疗途径。
Lancet Neurol. 2020 Oct;19(10):860-871. doi: 10.1016/S1474-4422(20)30277-5. Epub 2020 Sep 16.
8
Cerebrospinal Fluid and Blood Cytokines as Biomarkers for Multiple Sclerosis: A Systematic Review and Meta-Analysis of 226 Studies With 13,526 Multiple Sclerosis Patients.脑脊液和血液细胞因子作为多发性硬化症的生物标志物:对226项研究、13526例多发性硬化症患者的系统评价和荟萃分析
Front Neurosci. 2019 Oct 4;13:1026. doi: 10.3389/fnins.2019.01026. eCollection 2019.
9
Association between BDNF G196A (Val66Met) polymorphism and cognitive impairment in patients with Parkinson's disease: a meta-analysis.脑源性神经营养因子G196A(Val66Met)多态性与帕金森病患者认知障碍的关联:一项荟萃分析。
Braz J Med Biol Res. 2019;52(8):e8443. doi: 10.1590/1414-431X20198443. Epub 2019 Jul 29.
10
BDNF rs6265 polymorphism methylation in Multiple Sclerosis: A possible marker of disease progression.BDNF rs6265 多态性甲基化与多发性硬化症:疾病进展的一个可能标志物。
PLoS One. 2018 Oct 23;13(10):e0206140. doi: 10.1371/journal.pone.0206140. eCollection 2018.